Synthesis, biological evaluations and in silico studies on pyrimidine-appended fused pyrazolones as anticancer and antimicrobial agents
作者:Satbir Mor、Ravinder Punia、Mohini Khatri、Deepak Kumar、Ashwani Kumar、Deepak Kumar Jindal、Namita Singh、Renuka Sharma、Manzoor Ahmed、Sanket Shukla、Komal Jakhar
DOI:10.1016/j.molstruc.2023.136759
日期:2024.1
physical and spectral analysis data (FTIR, NMR (1H & 13C), 2D NMR and HRMS) and single-crystal X-ray crystallography. All were assayed for their in vitro anticancer activity against three human cancer cell lines viz. (i) human colorectal carcinoma (HCT116), (ii) human breast carcinoma (MCF7), and (iii) human prostate cancer (PC3) employing sulphorhodamine B assay by taking Camptothecin as the standard reference
22 个带有嘧啶和稠合吡唑药效团6a-k和7a-k的新型杂环杂化物已以良好的产率有效合成。它们的结构表征是通过物理和光谱分析数据(FTIR、NMR(1 H 和13 C)、2D NMR 和 HRMS)以及单晶 X 射线晶体学来实现的。所有这些都针对三种人类癌细胞系(即 )进行了体外抗癌活性测定。以喜树碱为标准参比药物,采用磺胺罗丹明 B 法测定 (i) 人结直肠癌 (HCT116)、(ii) 人乳腺癌 (MCF7) 和 (iii) 人前列腺癌 (PC3),并评估其在体外对两种革兰氏阳性菌株粪肠球菌(MTCC 439) 和金黄色葡萄球菌(NDRI 110)、两种革兰氏阴性菌株大肠杆菌(MTCC 723) 和伤寒沙门氏菌(MTCC 3224) 以及一种真菌菌株米根霉 (MTCC 3224)具有抗菌活性MTCC 262)采用定量显微分光光度法,分别以四环素和氟康唑作为抗菌和抗真菌测试的标准参比药物